Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown ...

U.S.-based pharmacy chain Walgreens Boots Alliance (WBA) suspended its long-standing dividend to preserve cash and prioritize its turnaround strategy. The company cited cash needs for the upcoming ...

as the company works toward achieving a retail pharmacy-led turnaround underpinned by a sustainable economic model," Walgreens said in a statement. The company added that its "cash needs over the ...

Additionally, Walgreens is facing ongoing structural challenges within the retail pharmacy sector. The company’s operating performance has been declining, with a notable reduction in its US ...

The largest health system in the Chicago area said it is shifting operations "after careful consideration" and will work to ...

The improving retail pharmacy business of Walgreens Boots Alliance and comments from the company’s ... [+] chief executive seem to be convincing Wall Street the drugstore chain is unlikely ...

Walgreens' CEO talked about the flip side of investing in increased security on a recent earnings call. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of ...

Walgreens’ first quarter earnings were notably better than Wall Street feared, though the retail pharmacy operator continues to suffer heavy losses as it works to right the ship. On Friday ...

stabilizing the retail pharmacy by optimizing our footprint, controlling operating costs, improving cash flow and continuing to address reimbursement models," said Walgreens CEO Tim Wentworth in a ...

Specialty pharmacy company Shields Health Solutions was a bright spot for the healthcare segment with 30% sales growth. Still, Walgreens has struggled to make U.S. healthcare a profitable part of ...

Shares of Walgreens dove early Friday, a day after the drugstore chain said it was suspending its dividend, breaking a streak of quarterly shareholder payouts that stretches back more than 90 years.

This includes Walgreens' clinic partner VillageMD growing revenue by 9% year over year, to $1.6 billion, specialty pharmacy Shields' revenue surging 30% to $200 million, and home-based patient ...